Hsu Yen-Bin, Chang Shyue-Yih, Lan Ming-Chin, Huang Jui-Lin, Tai Shyh-Kuan, Chu Pen-Yuan
Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, ROC.
J Chin Med Assoc. 2008 Feb;71(2):86-91. doi: 10.1016/S1726-4901(08)70080-7.
Head and neck cancer patients have a higher risk of developing a second primary malignancy (SPM) than the general population. This study was conducted to identify the characteristics of SPM and its impact on survival in patients with squamous cell carcinoma of the tongue (TSCC) and larynx (LSCC).
A retrospective study was conducted of 538 patients who were treated by surgery primarily for TSCC (n = 146) and LSCC (n = 392) from 1990 to 2000. The incidence, site, and overall survival of SPMs were evaluated.
Seventy-seven patients developed SPM during the follow-up period (median, 73 months), including 18 (12%) with TSCC and 59 (15%) with LSCC. Fifty-six percent of SPMs of the TSCC group appeared in the oral cavity. Among the SPMs of LSCC patients, 54% developed in the lung (31%) and larynx (24%). The 5-year overall survival after the diagnosis of SPM in the head and neck was 39%, compared to 29% for SPM in other areas (p = 0.010).
SPMs after treatment of TSCC and LSCC are similar in incidence but distinct in pattern. SPMs within the head and neck are associated with a better prognosis than those outside this area.
头颈部癌患者发生第二原发性恶性肿瘤(SPM)的风险高于普通人群。本研究旨在确定舌鳞状细胞癌(TSCC)和喉鳞状细胞癌(LSCC)患者中SPM的特征及其对生存的影响。
对1990年至2000年期间主要接受手术治疗的538例TSCC患者(n = 146)和LSCC患者(n = 392)进行回顾性研究。评估了SPM的发病率、部位和总生存率。
77例患者在随访期间发生SPM(中位时间为73个月),其中TSCC患者18例(12%),LSCC患者59例(15%)。TSCC组56%的SPM出现在口腔。在LSCC患者的SPM中,54%发生在肺部(31%)和喉部(24%)。头颈部诊断为SPM后的5年总生存率为39%,而其他部位为29%(p = 0.010)。
TSCC和LSCC治疗后的SPM发病率相似,但模式不同。头颈部内的SPM比该区域外的预后更好。